Sign in Pull a receipt

CBUS

Cibus, Inc.

Healthcare · Biotechnology

$86.06 sample

+0.28 (+0.33%) 1D

Market cap

$558.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-19

Alerts

8

Price$86.06 +4.29% 3M daily closessample

87.0478.95

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: Director
Oct 19SEC8-K filed: material event
Oct 13INSInsider sell: EVP, Operations
Oct 07INSInsider buy: EVP, Operations
Oct 02INSInsider sell: 10% owner
Sep 29INSInsider sell: 10% owner
Sep 18INSInsider buy: Director
Sep 10SECDEF 14A filed

Sign up to see the real CBUS record →

Company facts

SEC EDGAR registration

Name: Cibus, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -49sample, -100 to +100
Reporting currency: USD

Who is positioning in CBUS

sample

Insiders: 16 insider transactions over 90 days, net selling, $166.1M
Congress: 1 members traded over 90 days
Institutions · 13F: 16 funds hold $8.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$37.9B +19.2% y/y

Q4 2024Q3 2026

Inventory$23.2B +21.5% y/y

Q4 2024Q3 2026

Accounts receivable$16.2B +4.9% y/y

Q4 2024Q3 2026

Total debt$44.7B +8.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $493.2B +8.0% 3M
Sample peer B: $299.1B +4.1% 3M
Sample peer C: $433.5B -11.8% 3M
Sample peer D: $150.0B +11.6% 3M
Sample peer E: $234.7B +0.8% 3M